The Duke Specialty Pharmacy expansion is designed to better support patients through lower costs, broader treatment options and enhanced medication management.
Paclitaxel is indicated for the treatment of metastatic breast cancer, metastatic adenocarcinoma of the pancreas and locally advanced or metastatic non-small cell lung cancer.